ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Explore this paper's citation graph
Summary
A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions and to cover new topics in order to improve the quality of care for women with endometrian carcinoma across Europe and worldwide.
- Type
- article
- Published
- 2020-12-18
- Cited by
- 1,803
- References
- 472
- Access
- Open access
- OpenAlex
- https://openalex.org/W3114074286
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:229320840
Keywords
Medicine, Gynecologic oncology, Carcinoma, Gynecology, General surgery
References
- A Phase II Trial of Brivanib in Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
- Potential proton beam therapy for recurrent endometrial cancer in the vagina
- Can preoperative magnetic resonance imaging replace intraoperative frozen sectioning in the evaluation of myometrial invasion for early-stage endometrial carcinoma?
- Preliminary study
- Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer
- [Neoadjuvant chemotherapy].
- Preoperative MRI and Intraoperative Frozen Section Diagnosis of Myometrial Invasion In Patients With Endometrial Cancer
- Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients
- Conversion in endometrial cancer patients scheduled for laparoscopic staging: a large multicenter analysis
- Impact of Obesity on Surgical Treatment for Endometrial Cancer: A Multicenter Study Comparing Laparoscopy vs Open Surgery, with Propensity-Matched Analysis.
- Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS
- Validation of the Distress Thermometer worldwide: state of the science
- Integrated Genomic Characterization of Endometrial Carcinoma
- Three‐dimensional ultrasound with volume contrast imaging for preoperative assessment of myometrial invasion and cervical involvement in women with endometrial cancer
- A clinically applicable molecular-based classification for endometrial cancers
- Laparoscopic Sentinel Node Biopsy Using Real-time 3-dimensional Single-photon Emission Computed Tomographic Guidance in Endometrial Cancer.
- Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer.
- Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
- Robotic surgery for staging of serous papillary and clear cell carcinoma of the endometrium
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
Cited by
- A selective anatomically based lymph node sampling can replace a side specific pelvic lymphadenectomy in endometrial cancer with failed sentinel node mapping.
- Bone Metastases of Endometrial Carcinoma Treated by Surgery: A Report on 13 Patients and a Review of the Medical Literature
- Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data
- The Perspectives of Fertility Preservation in Women with Endometrial Cancer
- Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling
- Lumping and splitting: The need for precision medicine and “personomics” in endometrial cancer
- Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience
- Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer.
- Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.
- MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review
- New Insights into Endometrial Cancer
- The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions
- Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma.
- Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
- Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.
- [What's new in the management of endometrial cancer? Update on the new European recommendations for 2021].
- Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit.
- The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women
- Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting
- Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer
Related papers
- Hospital readmissions in gynecologic oncology patients: A target for quality improvement
- Report on NRG Oncology and the Gynecologic Oncology Group (GOG)
- Certification requirements for gynecologic oncology versus pelvic surgery: is gynecologic oncology too narrowing?
- Gynecologic oncology case studies : 40 case histories related to gynecologic oncology
- Gynecologic Oncology Providers' Attitudes and Practices regarding Sexuality in Cancer Survivors: A Gynecologic Oncology Fellow Research Network (GOFRN) Study
- An enhanced recovery pathway decreases length of hospital stay in gynecologic oncology patients undergoing minimally invasive surgery
- The Journal of Gynecologic Oncology and the Asian Society of Gynecologic Oncology: the history, the present and the future
- GYNECOLOGIC ONCOLOGY
- Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years.
- Nomogram predicting individual survival following recurrence in advanced stage high-grade ovarian cancer from NRG Oncology/Gynecologic Oncology Group randomized trials of platinum and paclitaxel